Product Information

FEIRZA 1.5 MG-30 MCG TABLET is a generic product labeled by Xiromed LLC, priced at $0.1412 per EA under NDC 70700030985. Its NADAC has been published 46 times since Aug 13, 2025.

Manufacturer

Xiromed LLC

NDC

70700030985

Classification

Generic

Dosage Form

KIT

Last Updated

6/17/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA202741

On Market Since

1/29/2025

Price Statistics

The NADAC for FEIRZA 1.5 MG-30 MCG TABLET has been published 46 times since Aug 13, 2025, and over the history we have for it it has declined 4.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1412 per EA
All-time high$0.1575 (Nov 12, 2025)
All-time low$0.1303 (Feb 18, 2026)
52-week high$0.1575
52-week low$0.1303
Median price$0.1456
Average price$0.1456
Largest weekly change-5.5% (Jan 21, 2026)
Weeks tracked46
Tracking sinceAug 13, 2025

Price History

1W

0.0%

1M

-4.5%

3M

+3.0%

6M

-3.0%

1Y

N/A

3Y

N/A

5Y

N/A

All

-4.8%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Norethindrone Acetate and Ethinyl Estradiol Tablets USP, 1.5 mg/30 mcg and Ferrous Fumarate Tablets, 75 mg market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Frequently asked questions

What is the NADAC price of FEIRZA 1.5 MG-30 MCG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for FEIRZA 1.5 MG-30 MCG TABLET, manufactured by Xiromed LLC, is $0.1412 per EA (NDC 70700030985), effective Jun 24, 2026.

How has the price of FEIRZA 1.5 MG-30 MCG TABLET changed over time?

Over the history we have for it, the NADAC for FEIRZA 1.5 MG-30 MCG TABLET has declined 4.8%. It has been tracked across 46 weekly CMS publications since Aug 13, 2025.

What are the highest and lowest recorded NADAC prices for FEIRZA 1.5 MG-30 MCG TABLET?

Since Aug 13, 2025, the NADAC for FEIRZA 1.5 MG-30 MCG TABLET has ranged from a low of $0.1303 (Feb 18, 2026) to a high of $0.1575 (Nov 12, 2025), with a median of $0.1456 per EA.

Are there cheaper alternatives to FEIRZA 1.5 MG-30 MCG TABLET?

No other NADAC-published product currently shares the active ingredient, strength, and dosage form of FEIRZA 1.5 MG-30 MCG TABLET, so no direct lower-cost alternative is listed.

Who manufactures FEIRZA 1.5 MG-30 MCG TABLET?

FEIRZA 1.5 MG-30 MCG TABLET (NDC 70700030985) is labeled by Xiromed LLC, and CMS classifies it as a generic product.

Related Drugs

Same classification

No related drugs found.